A novel model for extrapleural cavity metastasis assessment in patients with lung cancer

Biomark Med. 2021 Apr;15(6):389-399. doi: 10.2217/bmm-2020-0413. Epub 2021 Mar 12.

Abstract

Aim: To investigate the clinical value of tumor markers in extrapleural tumor metastasis assessment of newly diagnosed lung cancer patients. Materials & methods: This study retrospectively analyzed 306 patients diagnosed with lung cancer accompanied by tumor metastasis. Patients were grouped into extrapleural tumor metastasis and intrapleural tumor metastasis. Seven serum tumor markers were included for analysis. Results: The area under curves of receiver operating characteristic curve based on binning decision tree algorithm were above 0.8 in both training and validation sets. A scorecard with a score below 3 suggested extrapleural tumor metastasis in newly diagnosed lung cancer patients. Conclusion: The serum tumor marker-derived model is a convenient and fast approach for extrapleural cavity metastasis assessment, which may provide positive implications in newly diagnosed lung cancer patients.

Keywords: CA125; CA72-4; CEA; decision tree; extrapleural cavity metastasis; lung cancer; optimal binning algorithm; serum tumor biomarker; step regression analysis; tumor size.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers, Tumor / blood*
  • CA-125 Antigen / blood*
  • Carcinoembryonic Antigen / blood*
  • Female
  • GPI-Linked Proteins / blood
  • Humans
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology*
  • Male
  • Membrane Proteins / blood*
  • Middle Aged
  • Neoplasm Metastasis
  • Phosphopyruvate Hydratase / blood*
  • Prognosis
  • ROC Curve
  • Retrospective Studies

Substances

  • Biomarkers, Tumor
  • CA-125 Antigen
  • CEACAM5 protein, human
  • Carcinoembryonic Antigen
  • GPI-Linked Proteins
  • MUC16 protein, human
  • Membrane Proteins
  • ENO2 protein, human
  • Phosphopyruvate Hydratase